RxDoctor Payments Data

William Orr, MD

Psychiatry · Athens, GANPI 1073573390

Payments from drug & device makers

$520in general payments, 2019–2025

Across 23 payments — averaging $22.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$132
  • Sunovion Pharmaceuticals Inc.$113
  • Vanda Pharmaceuticals Inc.$49
  • Avanir Pharmaceuticals, Inc.$33
  • Otsuka America Pharmaceutical, Inc.$32
  • Johnson & Johnson$27
  • plus $135 from 7 others

What the payments were for

  • Food & beverage$520100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$520 in reported general payments places this provider in the 55th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia

Medicare billing

Part B allowed, 2024
$94,132
Medicare patients
98
Services billed
1,239

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine28$211,740
TrintellixVortioxetine Hydrobromide23$20,236
XanaxAlprazolam27$16,486
ZoloftSertraline Hcl12$7,213
Desvenlafaxine Succinate ErDesvenlafaxine Succinate49$4,607
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine153$4,280
Bupropion Hcl SrBupropion Hcl278$4,251
Armodafinil23$4,147
Duloxetine Hcl210$3,881
Gabapentin263$3,758
Wellbutrin SrBupropion Hcl12$2,460
Trazodone Hcl297$2,411
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine42$2,406
Quetiapine Fumarate65$2,259
Lisdexamfetamine Dimesylate12$2,174

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$22$20,23623 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 900 psychiatry providers in Georgia.

Other psychiatry in Athens

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →